Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Original Research

Published on 16 Jan 2023

Neuronal surface antigen-specific immunostaining pattern on a rat brain immunohistochemistry in autoimmune encephalitis

in Multiple Sclerosis and Neuroimmunology

Naomi Nagata
Naomi Kanazawa
Tomomi Mitsuhata
Masaki Iizuka
Makoto Nagashima
Masaaki Nakamura
Juntaro Kaneko
Eiji Kitamura
Kazutoshi Nishiyama
Takahiro Iizuka

Frontiers in Immunology

doi 10.3389/fimmu.2022.1066830

8,216 views
16 citations

Case Report

Published on 12 Jan 2023

Case report: Autoimmune encephalitis with multiple auto-antibodies with reversible splenial lesion syndrome and bilateral ovarian teratoma

in Multiple Sclerosis and Neuroimmunology

Yaqiang Li
Mei Zhang
Deshun Liu
Ming Wei
Jun Sheng
Zhixin Wang
Song Xue
Tingting Yu
Weimin Xue
Beibei Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2022.1029294

4,348 views
8 citations

Review

Published on 12 Jan 2023

Review: The role of HMGB1 in spinal cord injury

in Multiple Sclerosis and Neuroimmunology

Yizhang Mo
Kebing Chen

Frontiers in Immunology

doi 10.3389/fimmu.2022.1094925

5,089 views
9 citations

Original Research

Published on 10 Jan 2023

A single-cell atlas reveals the heterogeneity of meningeal immunity in a mouse model of Methyl CpG binding protein 2 deficiency

in Multiple Sclerosis and Neuroimmunology

Huiping Li
Meixin Hu
Zhuxi Huang
Yi Wang
Ying Xu
Jingxin Deng
Ming Zhu
Weijun Feng
Xiu Xu

Frontiers in Immunology

doi 10.3389/fimmu.2022.1056447

5,128 views
5 citations

Review

Published on 09 Jan 2023

The therapeutic potential of non-invasive brain stimulation for the treatment of Long-COVID-related cognitive fatigue

in Multiple Sclerosis and Neuroimmunology

Stefanie Linnhoff
Lilli Koehler
Aiden Haghikia
Tino Zaehle

Frontiers in Immunology

doi 10.3389/fimmu.2022.935614

11,857 views
25 citations

Review

Published on 06 Jan 2023

Immune response following traumatic spinal cord injury: Pathophysiology and therapies

in Multiple Sclerosis and Neuroimmunology

Robert C. Sterner
Rosalie M. Sterner

Frontiers in Immunology

doi 10.3389/fimmu.2022.1084101

24,293 views
126 citations

Original Research

Published on 05 Jan 2023

Safety and efficacy of plasma exchange treatment in children with AQP4-IgG positive neuromyelitis optica spectrum disorder

in Multiple Sclerosis and Neuroimmunology

Zhichao Li
Lin Wan
Xinting Liu
Jing Wang
Xiuyu Shi
Huanfen Zhou
Quangang Xu
Shihui Wei
Guang Yang

Frontiers in Immunology

doi 10.3389/fimmu.2022.1113406

2,842 views
7 citations

Original Research

Published on 05 Jan 2023

CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis

in Multiple Sclerosis and Neuroimmunology

Jinyi Li
Hongyan Li
Yunhuan Wang
Xiuhe Zhao
Shengjun Wang
Ling Li

Frontiers in Immunology

doi 10.3389/fimmu.2022.1071219

2,979 views
3 citations

Original Research

Published on 27 Dec 2022

Soluble TREM2 is a potential biomarker for the severity of primary angiitis of the CNS

in Multiple Sclerosis and Neuroimmunology

Tianshu Guo
Jia Ma
Jiali Sun
Wangshu Xu
Hengri Cong
Yuzhen Wei
Yuetao Ma
Qiaoxi Dong
Yunting Kou
Linlin Yin

Frontiers in Immunology

doi 10.3389/fimmu.2022.963373

4,162 views
4 citations

Original Research

Published on 23 Dec 2022

Frequent somatic mosaicism in T lymphocyte subsets in individuals with and without multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Lies Van Horebeek
Nina Dedoncker
Bénédicte Dubois
An Goris

Frontiers in Immunology

doi 10.3389/fimmu.2022.993178

2,700 views
6 citations

Original Research

Published on 23 Dec 2022

Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab

in Multiple Sclerosis and Neuroimmunology

Saskia Räuber
Alice Willison
Melanie Korsen
Tristan Kölsche
Kristin S. Golombeck
Benedikt Plaack
Julia Schüller
Niklas Huntemann
Leoni Rolfes
Christina B. Schroeter

Frontiers in Immunology

doi 10.3389/fimmu.2022.1037214

3,901 views
8 citations

Review

Published on 22 Dec 2022

Neuroinflammation in Huntington’s disease: From animal models to clinical therapeutics

in Multiple Sclerosis and Neuroimmunology

Qingqing Jia
Shihua Li
Xiao-Jiang Li
Peng Yin

Frontiers in Immunology

doi 10.3389/fimmu.2022.1088124

7,178 views
38 citations

Review

Published on 19 Dec 2022

Neurotrophic and immunomodulatory effects of olfactory ensheathing cells as a strategy for neuroprotection and regeneration

in Multiple Sclerosis and Neuroimmunology

Simona Denaro
Simona D’Aprile
Cristiana Alberghina
Anna Maria Pavone
Filippo Torrisi
Sebastiano Giallongo
Lucia Longhitano
Giuliana Mannino
Debora Lo Furno
Agata Zappalà

Frontiers in Immunology

doi 10.3389/fimmu.2022.1098212

4,028 views
15 citations

Review

Published on 16 Dec 2022

The relationship between chronic immune response and neurodegenerative damage in long COVID-19

in Multiple Sclerosis and Neuroimmunology

José Pedro Elizalde-Díaz
Clara Leticia Miranda-Narváez
Juan Carlos Martínez-Lazcano
Eduardo Martínez-Martínez

Frontiers in Immunology

doi 10.3389/fimmu.2022.1039427

13,597 views
35 citations

Brief Research Report

Published on 15 Dec 2022

The diagnosis of anti-LGI1 encephalitis varies with the type of immunodetection assay and sample examined

in Multiple Sclerosis and Neuroimmunology

Guillermo Muñoz-Sánchez
Jesús Planagumà
Laura Naranjo
Rocío Couso
Lidia Sabater
Mar Guasp
Eugenia Martínez-Hernández
Francesc Graus
Josep Dalmau
Raquel Ruiz-García

Frontiers in Immunology

doi 10.3389/fimmu.2022.1069368

7,014 views
11 citations

Case Report

Published on 14 Dec 2022

Case Report: Isolated facial and trigeminal nerve palsy without ataxia in anti-GQ1b antibody syndrome secondary to Mycoplasma pneumonia

in Multiple Sclerosis and Neuroimmunology

Shuwen Deng
Lihong Yin
Wei Lu
Song Ouyang
Weifan Yin

Frontiers in Immunology

doi 10.3389/fimmu.2022.1062567

3,459 views
2 citations